...
机译:Ultrapotent抗体对不同传播的SARS-COV-2变体
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
Univ N Carolina Sch Med UNC Chapel Hill Sch Publ Hlth Dept Epidemiol Chapel Hill NC 27599 USA|Univ N Carolina Sch Med Dept Microbiol & Immunol Chapel Hill NC 27599 USA;
Frederick Natl Lab Canc Res Canc Res Technol Program Electron Microscopy Lab Leidos Biomed Res Frederick MD 21702 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
Natl Hlth Lab Serv NHLS Natl Inst Communicable Dis NICD Johannesburg South Africa|Univ Witwatersrand Fac Hlth Sci Sch Pathol SAMRC Antibody Immun Res Unit Johannesburg South Africa;
Natl Hlth Lab Serv NHLS Natl Inst Communicable Dis NICD Johannesburg South Africa|Univ Witwatersrand Fac Hlth Sci Sch Pathol SAMRC Antibody Immun Res Unit Johannesburg South Africa;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
Frederick Natl Lab Canc Res Canc Res Technol Program Electron Microscopy Lab Leidos Biomed Res Frederick MD 21702 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
Natl Hlth Lab Serv NHLS Natl Inst Communicable Dis NICD Johannesburg South Africa|Univ Witwatersrand Fac Hlth Sci Sch Pathol SAMRC Antibody Immun Res Unit Johannesburg South Africa;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
Univ N Carolina Sch Med UNC Chapel Hill Sch Publ Hlth Dept Epidemiol Chapel Hill NC 27599 USA|Univ N Carolina Sch Med Dept Microbiol & Immunol Chapel Hill NC 27599 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
NIAID Vaccine Res Ctr NIH Bethesda MD 20892 USA;
机译:Ultrapotent人类抗体通过多种机制保护SARS-COV-2攻击
机译:与SARS-COV-2变体B.1.1.7相关的症状,再感染和传染性的变化:生态学研究
机译:在硅分析中,增加弹性蛋白酶敏感性和较大的传输501Y.V1和501Y.v2变体的钉蛋白-2中的分子内相互作用减少
机译:COV2K:SARS-COV-2变体影响的知识库
机译:一种控制和调节经典补体途径的新方法:使用工程化的单链抗体可变片段高度特异性地抑制C1q球头与人IgG的结合;使用截短的双特异性抗体将C1q募集到HER2 / neu阳性细胞
机译:增加弹性酶敏感性和在硅分析中更传播的501Y.V1和501Y.V2 SARS-COV-2变体的刺蛋白-NIARS-COV-2变体的敏感酶敏感性和分子内相互作用降低
机译:Ultrapotent SARS-COV-2中和抗体具有保护效果的抗体,针对新出现的突变变异性